Remdesivir Suspended Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) Treatment

IndicationsStatusPurposePhase
SuspendedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04252664A Trial of Remdesivir in Adults With Mild and Moderate COVID-19